tradingkey.logo

Transmedics Group Inc

TMDX
查看详细走势图
135.060USD
+5.460+4.21%
收盘 02/06, 16:00美东报价延迟15分钟
4.61B总市值
49.90市盈率 TTM

Transmedics Group Inc

135.060
+5.460+4.21%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+4.21%

5天

+0.81%

1月

+1.80%

6月

+13.69%

今年开始到现在

+11.02%

1年

+83.76%

查看详细走势图

TradingKey Transmedics Group Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Transmedics Group Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名48/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价146.00。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Transmedics Group Inc评分

相关信息

行业排名
48 / 205
全市场排名
138 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

Transmedics Group Inc亮点

亮点风险
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
业绩高增长
公司营业收入稳步增长,连续3年增长372.44%
业绩转盈
公司业绩转盈,最新年度盈利美元
估值合理
公司最新PE估值49.90,处于3年历史合理位
机构减仓
最新机构持股38.04M股,环比减少12.69%
乔尔·格林布拉特持仓
明星投资者乔尔·格林布拉特持仓,最新持仓市值8.24K

分析师目标

根据 14 位分析师
买入
评级
146.000
目标均价
+12.65%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Transmedics Group Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Transmedics Group Inc简介

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
公司代码TMDX
公司Transmedics Group Inc
CEOHassanein (Waleed H)
网址https://www.transmedics.com/
KeyAI